Article
Non-cytomembrane PD-L1: An atypical target for cancer
24 Jun 2021
Abstract excerpt
Programmed death ligand 1 (PD-L1) has conventionally been considered as a type I transmembrane protein that can interact with its receptor, programmed cell death 1 (PD-1), thus inducing T cell deactivation and immune escape. However, targeting the PD-1/PD-L1 axis has achieved adequate clinical responses in very few specific malignancies. Recent studies have explored the extracellularly and subcellularly located...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
